The tariff classification of Divalproex Sodium DR Tablets, Divalproex Sodium ER Tablets, Divalproex Sodium Sprinkle Capsules and Hydroxychloroquine Sulfate Tablets in dosage form, from India
Reasoning
The tariff classification of Divalproex Sodium DR Tablets, Divalproex Sodium ER Tablets, Divalproex Sodium Sprinkle Capsules and Hydroxychloroquine Sulfate Tablets in dosage form, from India
Cite this ruling
CBP Ruling N017941 (3004909110): The tariff classification of Divalproex Sodium DR Tablets, Divalproex Sodium ER Tablets, Divalproex Sodium Sprinkle Capsules and Hydroxychloroquine Sulfate Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
The tariff classification of liquid-filled glass vials ("cartridges") containing the investigational drug Exenatide (CAS-141732-76-5) as the active ingredient, and the tariff classification of a disposable pen injector fitted with a non-removable, liquid-filled glass vial ("cartridge") containing the investigational new drug Exenatide as the active ingredient, both from the United Kingdom